Liver Injury REMS Delays US FDA Approval Of Agios’s Pyrukynd In Thalassemia

 
• By Mandy Jackson
  
Analysts expect Pyrukynd to receive FDA approval to treat thalassemia despite the action date delay. (Shutterstock)

More from Drug Safety

More from United States